X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.

Freshfields Bruckhaus Deringer and Slaughter and May have taken lead roles on a $13bn (£9bn) deal which has seen GlaxoSmithKline (GSK) purchase a 36.5% stake in its consumer health joint venture with pharma giant Novartis.

Alex Berry

Alex joined Legal Week in July 2016. Before joining, Alex completed a MA in magazine journalism at City university and wrote freelance articles for a range of property titles. He reports on the in-house legal market

More from this author

Going PrivateBook

Whether your transaction is completed by LBO, merger, sale or reverse stock split, Going Private provides the practical and
thorough analysis you need
to help it survive scrutiny under governing leg.
Get More Information

 

Legal Week Newsletters & Alerts

Sign Up Today and Never Miss Another Story.

As part of your subscription, you can sign up for an unlimited number of a wide range of complimentary newsletters and alerts. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2019 American Lawyer Media International, LLC. All Rights Reserved.